RxDoctor Payments Data

Debbie Lo

Medical · San Diego, CANPI 1932422698

Payments from drug & device makers

$5,534in general payments, 2019–2025

Across 274 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$834
  • AstraZeneca$729
  • GSK$479
  • Johnson & Johnson$437
  • Sanofi-aventis U.S. LLC$428
  • Novo Nordisk$383
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$5,534100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,534 in reported general payments places this provider in the 85th percentile of 2,087 medical providers in California.

See all medical providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide11$11,894
PaxlovidNirmatrelvir/Ritonavir12$1,429
Ibandronate Sodium29$1,261
Rosuvastatin Calcium38$1,117
Bupropion XlBupropion Hcl16$766
Atorvastatin Calcium76$737
Losartan Potassium58$643
Levothyroxine Sodium61$580
Amlodipine Besylate38$406
Metoprolol Succinate25$307
Escitalopram Oxalate26$273
Doxycycline Hyclate13$237
Lisinopril31$231
Citalopram HbrCitalopram Hydrobromide15$226
Metformin Hcl27$204

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$227$11,89411 claims
PfizerPaxlovid$268$1,42912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 medical providers in California.

Other medical in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →